Rapid Therapeutic Science Laboratories
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,693,802 over the previous period. Total operating expenses were $1,263,333.
Profit Margin
| 2015 | 0 | -12.30K | |
|---|---|---|---|
| 2016 | 0 | -12.02K | |
| 2018 | 0 | -2.55M | |
| 2021 | 534 | -4.19M | -786015.73% |
| 2022 | 0 | -1.69M |
RTSL Income Statement (2014 – 2022)
| 2022 | 2021 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 534 | 0 | 0 | 0 |
Cost of revenue | 0 | 200 | 0 | 0 | 0 |
Gross profit | 0 | 334 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.26M | 2.17M | 152.07K | 12.02K | 12.30K |
Operating income | -1.26M | -2.17M | -2.52M | -12.02K | -12.30K |
Other income (expenses), net | -531.39K | -697.58K | -2.37M | 0 | 0 |
Income before tax | -1.79M | -2.86M | -2.55M | -12.02K | -12.30K |
Income tax expense | -100.92K | 1.32M | 28.60K | 0 | 0 |
Net income | -1.69M | -4.19M | -2.55M | -12.02K | -12.30K |
Earnings per share | |||||
Basic EPS | -0.22 | -0.55 | -25.88 | -0.11 | -0.11 |
Diluted EPS | -0.22 | -0.55 | -25.88 | -0.11 | -0.11 |
| Data source | Data source | Data source | Data source | Data source |